+924.9%
MRNA vs MRSH
+17.6%
+907.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -0.5% | -6.1% | -6.4% |
| 7D | +8.4% | +6.3% | +2.1% | +7.1% |
| 30D | +28.8% | +21.9% | +6.9% | +21.9% |
| 3M | +329.2% | +9.4% | +319.8% | +318.8% |
| 6M | +416.9% | +25.9% | +391.0% | +398.5% |
| YTD | +718.8% | +14.7% | +704.1% | +686.1% |
| 1Y | +924.9% | +19.3% | +905.6% | +864.5% |
| All | +924.9% | +17.6% | +907.3% | +864.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRSH.
Daily Out/Under-Performance
Portfolio return minus MRSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling